| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8631601 | Growth Hormone & IGF Research | 2018 | 4 Pages |
Abstract
The administration of rhIGF1 resulted in changes related to crucial metabolic pathways, including lipid and protein metabolism, and this could be associated with the previously reported treatment-induced improvement in the mild basal hyperinsulinemia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Annalaura Mastrangelo, Gabriel Á. Martos-Moreno, Francisco J. Rupérez, Julie A. Chowen, Coral Barbas, Jesús Argente,